Managed Healthcare Executive December 8, 2019
Oncology clinical pathways (OCPs) have been part of a growing trend for providers and payers. The American Society of Clinical Oncology (ASCO) reported a 42% increase from 2014 to 2016 in practices compliant with a pathway program based on an annual census of oncology practices. Protocols for OCPs include a wide variety of important aspects of delivering cancer care including anticancer drug treatment based on the stage and disease type. Oncology pathways balance various aspects of care including clinical efficacy, safety, toxicities, cost, and scientific advances. Additionally, ASCO is continuously raising awareness about high-quality OCPs among oncology providers, patients, and other stakeholders. This article will focus on OCPs and high-quality, value-based reimbursement models.
Today's Sponsors
Today's Sponsor